Nuclear PRMT5, cyclin D1 and IL-6 are associated with poor outcome in oropharyngeal squamous cell carcinoma patients and is inversely associated with p16-status. This evidence concerns the gene PRMT5 and oropharynx squamous cell carcinoma.